Institution
Retina Vitreous Associates of Florida
- 33running trials
- 16closed trials
- 103publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Recruiting
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
Recruiting
Enrolling by invitation
Active, not recruiting
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Active, not recruiting
Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration13 recruiting
- Diabetic eye disease3 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
Completed
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Completed
A Single Ascending Dose Cohort Study of AG-73305 in DME Patients
Completed
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
Completed
A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema
Completed
Completed
RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)
Terminated
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Completed
Terminated
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Terminated
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
Registry name variants (10)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Retina Vitreous Associates of Florida
St. Petersburg, Florida 33711
25 trials
Retina Vitreous Associates of Florida
Tampa, Florida 33617
10 trials
Retina Vitreous Associates of Florida - Saint Petersburg
St. Petersburg, Florida 33711
10 trials
Retina Vitreous Associates of Florida (RVA) - Saint Petersburg
St. Petersburg, Florida 33711-1141
2 trials
Retina Vitreous Associates of Florida (St. Petersburg)
St. Petersburg, Florida 33711
2 trials
Contact: Kodiak Sciences Inc
Contact: Kodiak Sciences Inc
Retina Vitreous Associates of Florida - St. Petersburg- Site Number : 8400002
St. Petersburg, Florida 33711
2 trials
Retina Vitreous Associates of Florida (Site 0036)
St. Petersburg, Florida 33711
1 trial
Contact: Study Coordinator
Retina Vitreous Associates of Florida (Site 049)
St. Petersburg, Florida 33711
1 trial
NCT07440225A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Contact: Study Coordinator
Retina Vitreous Associates of Florida - St. Petersburg
St. Petersburg, Florida 33711-1141
1 trial
Retina Vitreous Associates of Florida - St. Petersburg
St. Petersburg, Florida 33711-1141
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Macular degeneration13 works · 35 trials
Institution data: ROR 04993ye45 (CC0-1.0)Updated 15 Nov 2026